{"product_id":"injekcija-synvisc-16mg-2ml-3-svirkstai","title":"Injekcija Synvisc 16mg\/2ml 3 švirkštai","description":"\u003ch2\u003eTrumpai apie prekę\u003c\/h2\u003e\u003cp\u003ePrekė: Injekcija Synvisc 16mg\/2ml 3 švirkštai. Kategorija: Sąnariai, kaulai, raumenys.\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eGamintojas:\u003c\/strong\u003e Sanofi\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eModelis:\u003c\/strong\u003e 3401078489921\u003c\/li\u003e\n\u003c\/ul\u003e \u003cp\u003e\u003cb\u003eSYNVISC HYLAN GF20 16mg\/2ml x 3 amp.-syringe\u003c\/b\u003e - treatment of pain associated with osteoarthritis.\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSYNVISC HYLAN GF20 16mg\/2ml \u003c\/b\u003e- pain reduction, discomfort reduction, joint mobility increase!\u003c\/p\u003e \u003cp\u003e\u003cb\u003eGIFT: Set of patches for children\u003c\/b\u003e\u003c\/p\u003e\u003cp\u003eSYNVISC HYLAN GF20 16mg\/2ml x 3 amp.-syringe + Set of patches for children\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSynvisc Hylan GF20 16mg\/2ml x 3 amp.-syringe\u003c\/b\u003e Hylates are derivatives of hyaluronic acid sodium salt, which contain repetitive \u003cb\u003edisaccharide units of N-acetyl-glucosamine and sodium glucuronide. \u003c\/b\u003e Hylan A has an average molecular weight of approx. 6 000 000 Daltons, and Hylan B is a hydrated gel.\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSynvisc Hylan G-F 20 16mg\/2ml \u003c\/b\u003e has a therapeutic effect through viscosupplementation – a process in which the physiological and rheological state of the tissues of the joint altered by inflammation is restored.\u003c\/p\u003e \u003cp\u003e\u003cb\u003eIndications for use: \u003c\/b\u003e\u003c\/p\u003e \u003cul\u003e \u003cli\u003efor the periodic replacement and replenishment of synovial fluid;\u003c\/li\u003e \u003cli\u003ein patients at different stages of osteoarthritis;\u003c\/li\u003e \u003cli\u003ein patients who actively and regularly use the joint covered by the disease;\u003c\/li\u003e \u003c\/ul\u003e \u003cp\u003eViscosupplementation with hylan G‐F 20 is designed to reduce pain and discomfort and increase joint mobility. In vitro studies have shown that hylan G‐F 20 protects cartilage cells from some physical and chemical damage.\u003c\/p\u003e \u003cp\u003e\u003cb\u003eSYNVISC\u003c\/b\u003e can only be administered by a physician intraarticularly to treat pain associated with osteoarthritis of the knee, hip, ankle and shoulder \u003cb\u003ejoints.\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e\u003cb\u003eContraindications: \u003c\/b\u003e Do not use in patients with hypersensitivity to hyaluronic acid and other ingredients contained in the product. Injections into the joint cavity are contraindicated for current or past skin disease infections in the injection area.\u003c\/p\u003e \u003cp\u003eDo not inject intravenously or post-articularly.\u003c\/p\u003e \u003cp\u003e\u003cb\u003eUsage:\u003c\/b\u003e Product to be used \u003cb\u003eonly by authorised healthcare professionals.\u003c\/b\u003e \u003cb\u003eBefore use, read the information on the use of the medical device and consult a doctor.\u003c\/b\u003e\u003c\/p\u003e \u003cul\u003e \u003cli\u003eUse topically, in bulk.\u003c\/li\u003e \u003cli\u003eDo not use the SYNVISC medical device if the packaging has been opened or damaged before.\u003c\/li\u003e \u003cli\u003eThe contents of the syringe should be used immediately after opening the pack.\u003c\/li\u003e \u003cli\u003eRemove synovial fluid or exudate from the knee before injecting Hylan G‐F 20\u003c\/li\u003e \u003cli\u003eInject at room temperature.\u003c\/li\u003e \u003cli\u003eTo remove the syringe from the blister (or tray), hold the syringe by the body without touching the plunger.\u003c\/li\u003e \u003cli\u003eAdminister with strict aseptic technique, especially when removing the stopper from the vial.\u003c\/li\u003e \u003cli\u003eBefore removing the grey safety cap, it must be turned. This will minimize the leakage of the medical device.\u003c\/li\u003e \u003cli\u003eTo ensure tightness and prevent leakage, the needle should be firmly attached during feeding, while holding the Luer fitting firmly.\u003c\/li\u003e \u003cli\u003eDo not overtighten the needle or apply excessive pressure to the needle while applying or removing the needle cover, as this may break the tip of the syringe.\u003c\/li\u003e \u003cli\u003eThe device should only be administered into the synovial gland if necessary using fluoroscopy, in particular before administration into the hip or shoulder joint.\u003c\/li\u003e \u003cli\u003eThe contents of the syringe are for single use only.\u003c\/li\u003e \u003cli\u003eDo not reuse the syringe and\/or needle – reuse of syringes, needles and\/or medical device from the syringe used may result in loss of sterility, contamination of the device and\/or incomplete treatment.\u003c\/li\u003e \u003cli\u003eHylan G-F 20 should not be re-sterilized.\u003c\/li\u003e \u003c\/ul\u003e \u003cp\u003e\u003cb\u003eRecommended dosage:\u003c\/b\u003e The recommended dosage depends on the joint to which \u003cb\u003eSYNVISC (Hylan G‐F 20) is to be administered.\u003c\/b\u003e\u003c\/p\u003e \u003cul\u003e \u003cli\u003eOsteoarthritis \u003cb\u003eknee joint:\u003c\/b\u003e The recommended dosage is three injections of 2 ml into the knee joint with a one-week interval between each administration. In order to achieve the full therapeutic effect, it is important to administer all three doses. The maximum recommended dose is 6 injections over 6 months with at least a 4‐ week interval between administrations;\u003c\/li\u003e \u003cli\u003eosteoarthritis\u003cb\u003e of the hip, ankle, shoulder joint:\u003c\/b\u003e The recommended starting dose is 2 ml injection. If symptoms have not improved after the first administration, it is recommended to give another 2 ml injection.\u003c\/li\u003e \u003c\/ul\u003e \u003cp\u003eClinical data have shown benefit to the patient from the second injection if given between 1 and 3 months after the first administration. The duration of action of Hylan G‐F 20 affects only the joint within which the injection was given. It does not cause any effects at the systemic level.\u003c\/p\u003e \u003cp\u003eEffects in responders were reported up to 26 weeks after administration of the medical device, but a shorter or longer duration of action was also observed. Clinical data from the treatment of osteoarthritis of the knee have shown efficacy. effects up to 52 weeks after a series of three injections of SYNVISC.\u003c\/p\u003e \u003cp\u003e\u003cb\u003ePackaging: \u003c\/b\u003e3 pre-filled syringes of 2 ml\u003c\/p\u003e \u003cp\u003e\u003cb\u003eComposition:\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003e1 ml of G-F 20 hylan contains:\u003c\/p\u003e \u003cul\u003e \u003cli\u003ehylan 8,0mg ,\u003c\/li\u003e \u003cli\u003esodium chloride 8,5mg,\u003c\/li\u003e \u003cli\u003edisodium hydrogen phosphate 0,16mg,\u003c\/li\u003e \u003cli\u003esodium diphosphate monohydrate 0,04mg,\u003c\/li\u003e \u003cli\u003ewater for injections q.s.\u003c\/li\u003e \u003c\/ul\u003e \u003cp\u003e\u003cb\u003eManufacturer:\u003c\/b\u003e Genzyme Europe\u003c\/p\u003e\u003ch2\u003eSpecifications\u003c\/h2\u003e\u003ctable\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eGroup\u003c\/th\u003e\n\u003cth\u003eName\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eParametry\u003c\/td\u003e\n\u003ctd\u003eCondition\u003c\/td\u003e\n\u003ctd\u003enew\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eParametry\u003c\/td\u003e\n\u003ctd\u003eInvoice\u003c\/td\u003e\n\u003ctd\u003eWith VAT invoice\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eParametry\u003c\/td\u003e\n\u003ctd\u003eManufacturer code\u003c\/td\u003e\n\u003ctd\u003e3401078489921\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eParametry\u003c\/td\u003e\n\u003ctd\u003eProduct weight with unit packaging\u003c\/td\u003e\n\u003ctd\u003e0.01 kg\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eParametry\u003c\/td\u003e\n\u003ctd\u003eForm\u003c\/td\u003e\n\u003ctd\u003evial\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eParametry\u003c\/td\u003e\n\u003ctd\u003eNumber of pieces\u003c\/td\u003e\n\u003ctd\u003e3 pcs\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eParametry\u003c\/td\u003e\n\u003ctd\u003eVolume\u003c\/td\u003e\n\u003ctd\u003e2 ml\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eParametry\u003c\/td\u003e\n\u003ctd\u003eBrand\u003c\/td\u003e\n\u003ctd\u003eSanofi\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eParametry\u003c\/td\u003e\n\u003ctd\u003eBasic ingredient\u003c\/td\u003e\n\u003ctd\u003ehyaluronic acid\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eParametry\u003c\/td\u003e\n\u003ctd\u003eAdditional features\u003c\/td\u003e\n\u003ctd\u003esafe for breastfeeding women\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eParametry\u003c\/td\u003e\n\u003ctd\u003eEAN (GTIN)\u003c\/td\u003e\n\u003ctd\u003e3401078489921\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e","brand":"Dr.Max Drogeria","offers":[{"title":"Default Title","offer_id":46054043451452,"sku":"18527045018","price":238.87,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0618\/2161\/6188\/files\/Synvisc-inj-16mg-2ml-3-strz.jpg?v=1787608870","url":"https:\/\/market365.lt\/de\/products\/injekcija-synvisc-16mg-2ml-3-svirkstai","provider":"Market365","version":"1.0","type":"link"}